Category: Peripheral

Peripheral

luminor

Post author By abhishek
Post date August 13, 2022

Luminor

Paclitaxel eluting PTA balloon dilatation catheter
The DCB you need

PRODUCT FEATURES

Easy navigation

Small profiles

Short deflation times and wide size range (0.014”, 0.018” and 0.035” guidewire compatibilities)

Coating technology matters Not all DCBs are the same

Has an ultrathin coating thanks to the nanodrop technology used to coat the balloons.
Ensures a durable coating due to its multilayer technology, with minimum drug loss during navigation.
Ensures a uniform artery treatment

CLINICAL SUPPORT

Luminor has demonstrated its safety and efficacy in long term follow-up and in different indications:

EffPac Trial

Multicenter, randomized and controlled trial, Luminor vs POBA. 90.1% fTLR at 3.5 years

TINTIN Trial

Prospective, multicenter trial, with Luminor and iVolution combined therapy in TASC C&D lesions. 89.4% fTLR at 2 years

MERLION Trial

Prospective, multicenter trial, with Luminor and Angiolite BTK as bailout stenting in BTK. 81.6% fTLR at 1 year

Other trials: BIBLIOS,LUMBRA,LUMIFOLLOW, SOL JAPAN, LUMINOR registry.

Peripheral

iVolution pro

Post author By abhishek
Post date August 13, 2022

iVolution pro

Self-expanding peripheral stent system
Bring precision to treat your patients

PRODUCT FEATURES

Optimum visibility

iVolution pro has 2 markers delimiting the stent and 1 tungsten marker in the retractable sheath, indicating the implantation level.

Controlled and easy deployment

User-friendly stent thanks to its triple sheath design and ergonomic small handle. The deployment speed is modulated through the handle’s wheel.

Flexible and resistant stent design

The stress is homogeneously distributed to avoid stent fracture. iVolution pro open cell design offers the highest flexibility.

CLINICAL SUPPORT

iVolution pro has demonstrated its safety and efficacy in the following clinical trials

EVOLUTION Trial

Prospective, multicenter trial in femoropopliteal TASC A&B lesions. 88.0% fTLR at 1 year

TINTIN Trial

Prospective, multicenter trial, with Luminor and iVolution combined therapy in TASC C&D lesions. 89.4% fTLR at 2 years

Peripheral

Restorer

Post author By abhishek
Post date August 13, 2022

Restorer

Peripheral stent system
The illiac solution

PRODUCT FEATURES

Outstading catheter

Crimped on an Oceanus 35, offering short deflation times and great pushability and trackability.

Great profiles

6F compatible for all diameters.

Unique stent design

Provides superior conformability to the vessel wall.

Low restenosis

Advance manufacturing process to minimise the potential restenosis.

Q six, the certified quality of all iVascular stents

No random picking ensuring an automatized analysis of 100% stents. Assures the perfect surface finishing. Accurate dimensional analysis of the stent struts. 3D control, struts 100% checked.

Peripheral

Sergeant

Post author By abhishek
Post date August 13, 2022

Sergeant

Peripheral support catheter
To lead complex lesion procedures

PRODUCT FEATURES

Support to cross all lesions

Braided catheter with exceptional pushability and torque capacity.
Wide portfolio: 0.014”, 0.018” and 0.035” guidewire compatibility.

Able to go through tortuous arteries

Small profiles, all portfolio has 4Fr introducer compatibility.

Perfect visibility

The 4 radiopaque markers assess accurately:

Catheter position.
Lesion length.

Peripheral

Angiolite BTK

Post author By abhishek
Post date August 13, 2022

Angiolite BTK

Sirolimus eluting peripheral stent

PRODUCT FEATURES

Stent Design

High radial force with mínimum recoil to be able to treat BTK lesions.

Specifically designed for homogeneous arterial coverage.

Coating technology

TransferWise, the iVascular proprietary technology that provides a homogenous drug elution that translates into lower rates of restenosis and inflammation score.
Our fluoro-acrylate polymer provides an early endothelialization and creates a thromboresistant layer.

CLINICAL SUPPORT

Angiolite BTK has demonstrated its safety and efficacy in the following clinical trial:

ANGIOLITE BTK Trial

Prospective, real-life trial in BTK lesions. 88% PP at 6 months.

Peripheral

Oceanus

Post author By abhishek
Post date August 13, 2022

Oceanus

PTA peripheral balloon

PRODUCT FEATURES

Oceanus 14 pro

Designed for the most complex and distal lesions

Oceanus 18

Designed for all types of lesions in distal and proximal arteries

Oceanus 35

Designed for the proximal
lesions

Best flexibility and trackability

The smallest balloons (<2.5mm) have flexible tungsten markers and the bigger ones (>2.5mm) have Pt/Ir markers to ensure a good visibility.

High pushability and trackability

Excellent pushability in the proximal part and flexibility at the distal part.

High pushability

Ultra small balloons

Diameter: 1.25mm.
Length: 10 and 15 mm.

Smallest profiles

To cross the most complex lesions.

Long catheter lengthsy

170 and 200cm catheter available.

Peripheral

iCover

Post author By abhishek
Post date August 13, 2022

Oceanus

BX covered stent
You deserve visibility

PRODUCT FEATURES

Unique visibility

Unique balloon-expandable (BX) stent with radiopaque markers to facilitate the implantation and the post-expansion.

Excellent navigability and conformability

Outstanding flexibility
Small profiles
Best in class post-expansion capacity (≥2mm)

iVascular proprietary encapsulation technology

Proprietary technology to encapsulate the stent into an inner and outer ePTFE layer.

Ensures a complete encapsulation avoiding delamination.

Luminor

EffPac Trial

TINTIN Trial

MERLION Trial

iVolution pro

EVOLUTION Trial

TINTIN Trial

Restorer

Low restenosis

Q six, the certified quality of all iVascular stents

Sergeant

Angiolite BTK

ANGIOLITE BTK Trial

Oceanus

Oceanus

Recent Posts

Recent Comments

Archives

Categories

Our Marketing

Company

Newsletter